Xuyu Zhang

Prof. Xuyu Zhang

Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
YZYi-Nan Zhang
Yi-Nan Zhang
ZCZe-Nan Chang
Ze-Nan Chang
ZLZi-Meng Liu
Zi-Meng Liu
SWShi-Hong Wen
Shi-Hong Wen
YZYa-Qing Zhan
Ya-Qing Zhan
XZXuyu Zhang
Xuyu Zhang
BACKGROUND: Intestinal ischemia/reperfusion (I/R) challenge often results in gut barrier dysfunction and induces distant organ injury. Dexmedetomidine has been shown to protect intestinal epithelial barrier against I/R attack. The present study aims to investigate the degree to which intestinal I/R attack will contribute to gut-vascular barrier (GVB) damage, and to examine the ability of dexmedetomidine to minimize GVB and liver injuries in mice. METHODS: In vivo, intestinal ischemic challenge was induced in mice by clamping the superior mesenteric artery for 45 minutes. After clamping, the mice were subjected to reperfusion for either 2, 4, 6, or 12 hours. Intraperitoneal injection of dexmedetomidine 15, 20, or 25 μg·kg–1 was performed intermittently at the phase of reperfusion. For the in vitro experiments, the challenge of oxygen-glucose deprivation/reoxygenation (OGD/R) was established in cultured vascular endothelial cells, and dexmedetomidine (1 nM) was used to treat the cells for 24 hours. Moreover, in vivo and in vitro, SKL2001 (a specific agonist of β-catenin) or XAV939 (a specific inhibitor of β-catenin) was applied to determine the role of β-catenin in the impacts provided by dexmedetomidine. RESULTS: The attack of intestinal I/R induced GVB damage. The greatest level of damage was observed at 4 hours after intestinal reperfusion. There was a significant increase in plasmalemma vesicle–associated protein-1 (PV1, a specific biomarker for endothelial permeability) expression (5.477 ± 0.718 vs 1.000 ± 0.149; P < .001), and increased translocation of intestinal macromolecules and bacteria to blood and liver tissues was detected (all P < .001). Liver damages were observed. There were significant increases in histopathological scores, serum parameters, and inflammatory factors (all P < .001). Dexmedetomidine 20 μg·kg–1 reduced PV1 expression (0.466 ± 0.072 vs 1.000 ± 0.098; P < .001) and subsequent liver damages (all P < .01). In vitro, dexmedetomidine significantly improved vascular endothelial cell survival (79.387 ± 6.447% vs 50.535 ± 1.766%; P < .001) and increased the productions of tight junction protein and adherent junction protein (all P < .01) following OGD/R. Importantly, in cultured cells and in mice, β-catenin expression significantly decreased (both P < .001) following challenge. Dexmedetomidine or SKL2001 upregulated β-catenin expression and produced protective effects (all P < .01). However, XAV939 completely eliminated the protective effects of dexmedetomidine on GVB (all P < .001). CONCLUSIONS: The disruption of GVB occurred following intestinal I/R. Dexmedetomidine alleviated I/R-induced GVB impairment and subsequent liver damage.

23 December 2021 in Journal of Proteome Research
Verified
Journal Article
Closed access
SGSu Guan
Su Guan
KLKun Liu
Kun Liu
ZLZimeng Liu
Zimeng Liu
LZLiping Zhou
Liping Zhou
BJBingjie Jia
Bingjie Jia
XZXuyu Zhang
Xuyu Zhang

7 October 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
ZCZenan Chang
Zenan Chang
YZYinan Zhang
Yinan Zhang
MLMing Lin
Ming Lin
SWShihong Wen
Shihong Wen
HLHanjin Lai
Hanjin Lai
ZLZimeng Liu
Zimeng Liu
Gut-vascular barrier (GVB) serves as the last barrier to limit the migration of intestinal toxins into the blood circulation. The efficacy of terlipressin (a vasopressin V1 receptor agonist) in reducing GVB and multiple organ damage in gut-derived sepsis is unknown. In this study, we hypothesized that, besides other intestinal barriers, GVB play a key role in gut-derived sepsis and terlipressin improve GVB damage and then reduce bacterial translocation and organ injuries. In vivo, a cecal ligation and puncture mouse model was established. The mice were subjected to examine the damage of GVB determined by intestinal plasmalemma vesicle-associated protein-1(PV-1) and vascular endothelial-cadherin. And the intestinal permeability was assessed by translocation of intestinal bacteria and macromolecules. In vitro, transendothelial electrical resistance (TER) during interleukin (IL)-1β stimulation was measured on endothelial cells with or without small interfering RNA targeting β-catenin (si β-catenin). Terlipressin significantly improved GVB damage and reduced translocation of intestinal macromolecules and bacteria by activating PI3K signaling. Of note, intestinal PV-1 expression was significantly correlated with translocation of macromolecules, and dramatic increase of macromolecules was observed in intestinal tissues whereas fewer macromolecules and bacteria were observed in blood, liver and lung following terlipressin treatment. In vitro, terlipressin restored TER during IL-1β stimulation and si β-catenin transfection blocked the changes delivered by terlipressin. Collectively, terlipressin alleviated GVB damage and subsequent bacterial translocation via blood vessels after sepsis challenge, resulting in reduced distant organ injuries and the responsible mechanisms may involve the activation of PI3K/β-catenin pathway.

31 March 2023 in Journal of Proteome Research
Verified
Journal Article
Closed access
JHJiaxin Huang
Jiaxin Huang
ZWZichen Wang
Zichen Wang
XZXuyu Zhang
Xuyu Zhang
YGYuanyuan Gou
Yuanyuan Gou
JLJing Li
Jing Li
HZHufei Zhang
Hufei Zhang

9 February 2024 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
ZLZi-Meng Liu
Zi-Meng Liu
YZYi-Nan Zhang
Yi-Nan Zhang
HZHu-Fei Zhang
Hu-Fei Zhang
XCXiao-Jun Chen
Xiao-Jun Chen
HPHui Peng
Hui Peng
XZXuyu Zhang
Xuyu Zhang

1 January 2020 in International Journal of Medical Sciences
Verified
Journal Article
Open access
ZLZi-Meng Liu
Zi-Meng Liu
HLHan-Jin Lai
Han-Jin Lai
XGXiang-Dong Guan
Xiang-Dong Guan
SWShi-Hong Wen
Shi-Hong Wen
JSJian-Tong Shen
Jian-Tong Shen
XZXuyu Zhang
Xuyu Zhang
Background: To date, the effect of vasopressin on organ damages after acute mesenteric ischemia (MI) remains poorly understood.